Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Related Articles
Rabin’s Gold Standard: Cardiovascular Disease Clinical Research
Senior cardiologist from Rabin Medical Center, Dr. Alon Eisen, is the first doctor from Israel to participate in renowned TIMI (Thrombolysis in Myocardial Infarction) Study Group in the United States.
Never Too Old
Prof Moshe Salai, head of Orthopedics at Rabin Medical Center, told us that 30 years ago when he was just beginning his career, he was shocked to be told that there was no point in treating people over eighty years old suffering from fractures in the femoral neck.
Israeli Orthopedic Expert
On January 30, 2008, the American Physician
Friends of Rabin Medical Center hosted a
presentation by Dr. Moshe Salai, the Director
of the Dept. of Orthopedic Surgery at the
Rabin Medical Center.